Volume 5, Number 9
Monday, March 7, 2005



In this issue: (click heading to view article)
Evaluation of Image Artifact Produced by OCT of Retinal Pathology
Causes of Incident Visual Field Loss in the Elderly
Anesthetic Techniques and Postoperative Emesis in Pediatric Strabismus Surgery
Pulsatile Ocular Blood Flow in Patients with Graves" Ophthalmopathy
Briefly











Evaluation of Image Artifact Produced by OCT of Retinal Pathology

Optical coherence tomography (OCT) scan artifacts are seen surprisingly frequently, adversely affect retinal thickness measurements in a high proportion of cases and are diagnosis-dependent, according to Investigators at Duke University Eye Center in Durham, NC.

The researchers conducted a retrospective observational case series aimed at determining the frequency and type of optical coherence tomography (OCT) fast macular thickness map (FMTM) scan artifacts, and whether these artifacts depend on patient diagnosis, demographics and ocular therapy. The study included records from 171 eyes of patients who had undergone ophthalmologic evaluation by a Duke University Eye Center vitreoretinal faculty member, and who had had an OCT scan produced by the FMTM protocol between July 7, 2003, and July 31, 2003. Researchers determined the relationships between OCT scan artifacts and ocular diagnosis, ocular treatment and patient demographics. They used logistic regression to relate OCT scan artifacts simultaneously with ocular diagnosis and treatment.

Retinal scan artifacts, though not observed in normal eyes, were identified frequently in eyes with macular pathology. Artifacts were observed in 43.2 percent of all scans; of these, an erroneous retinal thickness measurement was obtained in 62.2 percent. Six types of OCT surface map artifacts were observed. Of these, inner and outer retinal misidentification, degraded image artifact and "off center" artifact were significantly associated with central thickness calculation errors. Neovascular age-related macular degeneration (AMD), full-thickness macular hole and photodynamic therapy were all associated with increased artifact. The authors believe that recognition of these artifacts will improve retinal thickness measurement accuracy, and will prevent faulty treatment decisions that are based on inaccurate retinal thickness measurements.

SOURCE: Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005;139(1):18-29.
Table of Contents











Causes of Incident Visual Field Loss in the Elderly

Investigators at Erasmus University Medical Center, the Netherlands, conducted a study aimed at determining the incidence and causes of visual field loss (VFL) in a general elderly population.

Investigators used suprathreshold perimetry to examine central visual fields of both eyes of 3,761 people aged 55 years or older who were free of VFL at baseline; the subjects were taken from the Rotterdam Study group. Goldmann perimetry was performed to confirm suprathreshold VFL. Causes of incident VFL (iVFL) were assessed based on all available ophthalmologic and neurological examination data and medical records.

After a mean follow-up time of 6.3 years, 175 people in the group developed VFL. The overall incidence rate of iVFL was 7.4 per 1,000 person-years, increasing to 21.1 per 1,000 person-years in those aged 80 and older. Glaucoma was the leading cause of iVFL in all age categories. The overall incidence of glaucomatous VFL was 2.0 per 1,000 person-years.

SOURCE: Skenduli-Bala E, de Voogd S, Wolfs RC, et al. Causes of incident visual field loss in a general elderly population: the Rotterdam study. Arch Ophthalmol 2005;123(2):233-8.
Table of Contents






Anesthetic Techniques and Post-operative Emesis in Pediatric Strabismus Surgery

Post-operative emesis after pediatric strabismus surgery continues to be a problem, despite the use of antiemetics. The purpose of this study by the Department of Anesthesiology and Intensive Care at the All India Institute of Medical Sciences, India, was to identify an anesthetic technique associated with the lowest incidence of vomiting after pediatric strabismus surgery.

Investigators conducted a prospective, randomized, double-blind study to evaluate the effect of intravenous fentanyl, meperidine or peribulbar block with propofol infusion on emesis in 105 pediatric patients undergoing strabismus surgery. Anesthesia was maintained with nitrous oxide, oxygen and propofol infusion. Ketorolac 1.0 mg/kg -1 intramuscular was administered to all patients after induction. Patients received either a peribulbar block, intravenous fentanyl 2 mg/kg -1 or intravenous meperidine 1mg/kg -1 for perioperative analgesia. Emesis scores were observed for the first 24 hours post-operatively.

The incidence of emesis was significantly lower (1 of 35 or 2.9 percent) in the peribulbar group compared with the meperidine group (9 of 35 or 25.6 percent) in the first 24 hours. The fentanyl group had a higher incidence of postoperative vomiting (4 of 35, or 11.4 percent) than did the peribulbar group, but the difference was not statistically significant.

SOURCE: Chhabra A, Pandey R, Khandelwal M, et al. Anesthetic techniques and postoperative emesis in pediatric strabismus surgery. Reg Anesth Pain Med 2005;30(1):43-7.
Table of Contents






Pulsatile Ocular Blood Flow in Patients with Graves" Ophthalmopathy

Graves" ophthalmopathy (GO) is a cosmetically disfiguring and vision-threatening complication of Graves" disease (GD). Taiwanese researchers recently investigated the clinical application of pulsatile ocular blood flow (POBF) measurement for detection of clinically active GO in a prospective study.

Using the OBF tonometer (OBF Labs, Wiltshire, UK), investigators measured POBF in 83 eyes of 83 patients with GD in two groups and 42 normal control subjects. Group A was comprised of 35 GD patients without ophthalmopathy; and Group B was comprised of 48 GD patients with ophthalmopathy. Results were compared with controls.

Pulse amplitude, pulse volume and POBF were significantly lower in Group B than in Group A and controls. After adjusting for age, sex, systolic blood pressure, diastolic blood pressure, heart rate, intraocular pressure and axial length, multivariate linear regression analysis showed that POBF was still significantly lower in eyes with GO (772.4 (SD 279.3) µl/min) than group A (1177.3 (SD 326.3) µl/min) and controls (1255.4 (SD 295.1) µl/min). The results show that POBF differences between the groups are relevant to the presence of GO, and that POBF measurement is a clinically useful adjunct for assessing the hemodynamic change in GO patients.

SOURCE: Tsai CC, Kau HC, Kao SC, et al. Pulsatile ocular blood flow in patients with Graves" ophthalmopathy. Eye 2005;19(2):159-62.
Table of Contents





BRIEFLY
  • VISX IRIS REGISTRATION PRODUCT APPROVED BY THE FDA. VISX, Inc., has received approval from the FDA to market and sell its Iris Registration technology, the first fully automated method of aligning and registering wavefront corrections for CustomVue treatment. Iris Registration is designed to replace manual marking of the eye to assess rotational movement. It is a hardware and software product enhancement that is field-installed as an upgrade to the VISX WaveScan and VISX Star laser systems. VISX intends to begin U.S. shipment of Iris Registration in the second quarter of 2005. For more information, go to www.VISX.com.
  • SCIENTISTS REGENERATE OPTIC NERVE FOR THE FIRST TIME. Scientists at the Schepens Eye Research Institute, Harvard Medical School, have regenerated a damaged optic nerve for the first time. The process, which was conducted in laboratory mice, is described in the March 1, 2005 issue of Journal of Cell Science. The research, led by Dr. Dong Feng Chen, is aimed at determining why CNS tissue in mammals loses its ability to regenerate after injury and at finding ways to reverse this process. Earlier research by this team showed that several processes seemed to "lock up" the optic nerve’s ability to regenerate. One such "lock" was the turning off of a specific gene that activates growth and regeneration. Another, the team believes, could be a "scar" on the brain that is created shortly after birth by glial cells; this scar may present a barrier to regeneration. In their current research, the investigators tested "keys" to unlock regeneration. The first was to develop a mouse model in which the growth and regeneration gene is always turned on; the second was to use a mouse line that has mutations of glial-specific genes that can reduce glial "scars." They found that the combination of the turned-on regeneration gene and the mutation of "glial specific genes" caused the optic nerves to return to an embryonic state and stimulated rapid and vigorous regeneration of the optic nerve within days. Dr. Chen and her colleagues have yet to determine whether these regenerated nerves are functional and actually cause the mice to see again, but they believe that the results hold great promise for regenerating not only optic nerves, but also other tissues of the CNS.
  • CE MARK GRANTED FOR FOURTH-GENERATION BIOMICROSCOPE. Paradigm Medical Industries, Inc., has received a CE Mark for a new ultrasound biomicroscope, the P60 UBM. The CE Mark will enable the company to market the device in 19 Western European countries and some parts of the Pacific Rim. The P60 UBM is a fourth-generation microprocessor-based, multi-frequency ultrasound biomicroscope that allows users to acquire and view high-resolution images of the anterior segment of the eye involved with glaucoma pathologies and related surgical filtering procedures. At lower frequency applications, it provides a view of the retinal area and is useful for diagnosing trauma to the vitreous body. Paradigm expects to begin selling the product immediately in Europe. Earlier versions of the device, including the P45, have received FDA approval for use in the United States.

Table of Contents



 Check Yearly. See Clearly. Open Your Eyes To the Opportunities.
It"s only been up and running a few short weeks. Yet, it"s already clear that the Check Yearly. See Clearly.(SM) marketing campaign is opening consumers" eyes to the benefits of regular eye exams. Call the Vision Council of America at 800-424-8422 today or visit checkyearly.com for your free promotional materials.